We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours (CC) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
Chemours (CC - Free Report) closed the most recent trading day at $32.44, moving +0.43% from the previous trading session. The stock outpaced the S&P 500's daily loss of 1.69%. At the same time, the Dow lost 1.19%, and the tech-heavy Nasdaq gained 0.14%.
Heading into today, shares of the chemical company had gained 22.53% over the past month, outpacing the Basic Materials sector's gain of 7.5% and the S&P 500's gain of 7.88% in that time.
Wall Street will be looking for positivity from Chemours as it approaches its next earnings report date. This is expected to be May 2, 2022. The company is expected to report EPS of $0.90, up 26.76% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.54 billion, up 7.04% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.51 per share and revenue of $6.67 billion, which would represent changes of +12.75% and +5.15%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Chemours. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Chemours is currently a Zacks Rank #3 (Hold).
Looking at its valuation, Chemours is holding a Forward P/E ratio of 7.16. This valuation marks a discount compared to its industry's average Forward P/E of 11.49.
Meanwhile, CC's PEG ratio is currently 0.56. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Chemical - Diversified stocks are, on average, holding a PEG ratio of 0.83 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 182, which puts it in the bottom 29% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Chemours (CC) Gains As Market Dips: What You Should Know
Chemours (CC - Free Report) closed the most recent trading day at $32.44, moving +0.43% from the previous trading session. The stock outpaced the S&P 500's daily loss of 1.69%. At the same time, the Dow lost 1.19%, and the tech-heavy Nasdaq gained 0.14%.
Heading into today, shares of the chemical company had gained 22.53% over the past month, outpacing the Basic Materials sector's gain of 7.5% and the S&P 500's gain of 7.88% in that time.
Wall Street will be looking for positivity from Chemours as it approaches its next earnings report date. This is expected to be May 2, 2022. The company is expected to report EPS of $0.90, up 26.76% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.54 billion, up 7.04% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.51 per share and revenue of $6.67 billion, which would represent changes of +12.75% and +5.15%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Chemours. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Chemours is currently a Zacks Rank #3 (Hold).
Looking at its valuation, Chemours is holding a Forward P/E ratio of 7.16. This valuation marks a discount compared to its industry's average Forward P/E of 11.49.
Meanwhile, CC's PEG ratio is currently 0.56. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Chemical - Diversified stocks are, on average, holding a PEG ratio of 0.83 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 182, which puts it in the bottom 29% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.